BIOGEN INC. Logo

BIOGEN INC.

Biotechnology company developing therapies for neurological and neurodegenerative diseases.

BIIB | US

Overview

Corporate Details

ISIN(s):
US09062X1037
LEI:
Country:
United States of America
Address:
225 BINNEY STREET, 2142 CAMBRIDGE

Description

Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-03 17:42
PRIMARY DOCUMENT
English 7.3 KB
2025-11-13 21:28 English 8.6 KB
2025-11-04 17:12
PRIMARY DOCUMENT
English 7.1 KB
2025-10-30 07:31
10-Q
English 4.8 MB
2025-10-30 07:13
8-K
English 185.6 KB
2025-10-14 18:19
8-K
English 80.9 KB
2025-10-06 15:00
PRIMARY DOCUMENT
English 7.0 KB
2025-09-02 19:56
PRIMARY DOCUMENT
English 7.3 KB
2025-09-02 14:54 English 7.0 KB
2025-07-31 08:13
8-K
English 177.3 KB
2025-07-31 08:05
10-Q
English 4.7 MB
2025-07-30 19:56 English 8.3 KB
2025-07-21 23:18 English 9.8 KB
2025-07-16 19:55
PRIMARY DOCUMENT
English 6.5 KB
2025-07-08 17:26 English 6.9 KB

Automate Your Workflow. Get a real-time feed of all BIOGEN INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOGEN INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOGEN INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.